Abstract
Reactive carbonyl species (RCS) are now considered to play an important role in Alzheimer's disease (AD) pathogenesis. Indeed, methylglyoxal (MGO) or malondialdehyde (MDA) are endogenously formed during the sugar glycoxidation and lipid peroxidation of polyunsaturated fatty acids induced by oxidative stress exacerbation. Their condensation with amino groups of tissue proteins leads to AGE (Advanced Glycation Endproducts) and ALE (Advanced Lipid peroxidation Endproducts) accumulation in amyloid β (Aβ) plaques and tau-associated neurofibrillary tangles (NFT). In AD, Aβ-oligomers induce oxidative stress whereas transition metals (Zn2+, Cu2+ and Fe3+) stimulate Aβ aggregation and APP (amyloid precursor protein) processing. Carbonyl stress takes part in this vicious downward redox amyloid spiral leading to neurodegeneration as oxidative stress promoter and toxic mediator.1,2 First, glycated Aβ cross-linking promotion accelerates its deposition and its protease resistance. Secondly, AGE/ALE formation not only accelerates tau hyperphosphorylation, disturbs the neuronal membrane depolarization process and the glucose transport but also exacerbates glutamate-mediated excitotoxicity. Thirdly, AGE promote oxidative stress and inflammation as well as cell apoptosis via their receptors RAGE.3 Taking into account the multifactorial pathogenesis of AD, we developed promising hybrid drugs that are simultaneously able to trap RCS (primary vicinal diamine function) as well as ROS and biometals (phenolic acid or hydroxypyridinone moiety).4 In the poster, synthesis of these new multifunctional AGE/ALE inhibitors and their physicochemical and biological evaluations (carbonyl trapping capacity, antioxidant activity, Cu2+-chelating capacity and protective properties against in vitro MGO-induced apoptosis in the model AD cell-line PC12) are reported. We thank “SATT Nord” for financial support of this study.
Highlights
Reactive carbonyl species (RCS) are considered to play an important role in Alzheimer's disease (AD) pathogenesis
With this in mind and taking into account the multifactorial pathogenesis of AD, we developed new promising multifunctional drugs that are simultaneously able to trap RCS as well as ROS and biometals (Figure 1)
AGE/ALE Inh 9 offered promising protective biological activity reducing in vitro MGO-induced apoptosis
Summary
Reactive carbonyl species (RCS) are considered to play an important role in Alzheimer's disease (AD) pathogenesis. With this in mind and taking into account the multifactorial pathogenesis of AD, we developed new promising multifunctional drugs that are simultaneously able to trap RCS (primary vicinal diamine function) as well as ROS and biometals (phenolic acid or hydroxypyridinone moiety) (Figure 1) .4
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.